A study of the brain structures involved in the acute effects of fluoxetine on REM sleep in the rat

International Journal of Neuropsychopharmacology

Volumn 8, Issue 1, 2005, Pages 75-86

  Monti, Jaime M ^a,b   Jantos, Hector ^a  

^a HOSPITAL DE CLÍNICAS   (Uruguay)

^b Dept of Pharmacol and Therapeutics ^*  (Uruguay)

Author keywords

Fluoxetine; REM sleep; Serotonin; Sleep; WAY 100635

Indexed keywords

FLUOXETINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN STEM; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; DRUG EFFECT; DRUG INFUSION; LATENT PERIOD; LATERODORSAL TEGMENTAL NUCLEUS; MALE; MEDIAL PONTINE RETICULAR FORMATION; NONHUMAN; PRIORITY JOURNAL; RAT; REM SLEEP; RETICULAR FORMATION; SLEEP; TEGMENTUM;

ANIMALS; BRAIN MAPPING; BRAIN STEM; DOMINANCE, CEREBRAL; DRUG ADMINISTRATION ROUTES; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; FLUOXETINE; MALE; NEURAL INHIBITION; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PIPERAZINES; PYRIDINES; RAPHE NUCLEI; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; RETICULAR FORMATION; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SLEEP; SLEEP, REM; WAKEFULNESS;

EID: 15244356041     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145704004511     Document Type: Article

References (54)

1. 1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram. Naunyn-Schmiedeberg's Archives of Pharmacology 352, 157-165.
2. Armitage R (1996). Effects of antidepressant treatment on sleep EEG in depression. Journal of Psychopharmacology 10 (Suppl. 1), 22-25.
3. Asberg M, Eriksson B, Martensson B, Traskman-Bendz L, Wagner A (1986). Therapeutic effects of serotonin uptake inhibitors in depression. Journal of Clinical Psychiatry 47, 23-35.
4. Baldessarini RJ (2001). Drugs and the treatment of psychiatric disorders. Depression and anxiety disorders. In: Hardman JG, Limbird LE (Eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics (pp. 447-483). New York: McGraw-Hill.
5. 1A receptor agonist given systematically as well as perfused in the dorsal raphe nucleus in rats. Brain Research 770, 81-88.
6. Bonvento G, Scatton B, Claustre Y, Rouquier L (1992). Effect of local injection of 8-OH-DPAT into the dorsal or medial raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain. Neuroscience Letters 137, 101-104.
7. Burchett SA, Bannon MJ (1997). Serotonin, dopamine and norepinephrine transporter mRNAs: heterogeneity of distribution and response to 'binge' cocaine administration. Molecular Brain Research 49, 95-102.
8. Dailey JW, Yan QS, Mishra PK, Burger RL, Jobe PC (1992). Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. Journal of Pharmacology and Experimental Therapeutics 260, 533-540.
9. 1B receptors control the firing of serotonergic neurons in the dorsal raphe nucleus of the mouse. European Journal of Neuroscience 11, 3823-3831.
10. Ferré S, Cortes R, Artigas F (1994). Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats. Journal of Neuroscience 14, 4839-4846.
11. Fuller RW (1994). Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sciences 55, 163-167.
12. Gao B, Duncan WC, Wehr TA (1992). Fluoxetine decreases brain temperature and REM sleep in Syrian hamsters. Psychopharmacology 106, 321-329.
13. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. British Journal of Pharmacology 115, 1064-1070.
14. Hajós M, Gartside SE, Sharp T (1995). Inhibition of median and dorsal raphe neurons following administration of the selective serotonin reuptake inhibitor paroxetine. Naunyn-Schmiedeberg's Archives of Pharmacology 351, 624-629.
15. Hilakivi I, Kovala A, Leppävuori A, Shvaloff A (1987). Effects of serotonin and noradrenaline uptake blockers on wakefulness and sleep in cats. Pharmacology and Toxicology 60, 161-166.
16. Hobson AJ, Stickgold P, Pace-Schott EF (1998). The neurophysiology of REM sleep dreaming. Neuroreport 9, R1-R14.
17. Honda T, Semba K (1994). Serotonergic synaptic input to cholinergic neurons in the rat pontine tegmentum. Brain Research 647, 299-308.
18. Horner RL, Sanford LD, Annis D, Pack AI, Morrison AR (1997). Serotonin at the laterodorsal tegmental nucleus suppresses rapid-eye-movement sleep in freely behaving rats. Journal of Neuroscience 17, 7541-7552.
19. Iwakiri H, Matsuyama K, Mori S (1993). Extracellular levels of serotonin in the medial pontine reticular formation in relation to sleep-wake cycle in cats: a microdialysis study. Neuroscience Research 18, 157-170.
20. Janowsky DS, Davis JM, El-Yousef MK, Sekerke HJ (1972). A cholinergic-adrenergic hypothesis of mania and depression. Lancet 2, 632-635.
21. Kia HK, Brisorgueil MJ, Hamon M, Calas A, Vergé D (1996a). Ultrastructural localization of 5-hydroxy-tryptamine1A receptors in the rat brain. Journal of Neuroscience Research 46, 697-708.
22. 1A receptors in the rat central nervous system. Journal of Comparative Neurology 365, 289-305.
23. Kimmel H, Vicentic A, Kuhar MJ (2001). Neurotransmitter transporters. Synthesis and degradation rates. Life Sciences 68, 2181-2185.
24. Knobelman DA, Hen R, Lucki I (2001). Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse. Journal of Pharmacology and Experimental Therapeutics 298, 1083-1091.
25. Kupfer DJ (1984). Neurophysiological 'markers' - EEG sleep measures. Journal of Psychiatric Research 18, 467-475.
26. Lemberger L, Fuller RW, Zerbe RL (1985). Use of specific serotonin reuptake inhibitors as antidepressants. Clinical Neuropharmacology 8, 299-317.
27. McCarley RW, Hobson JA (1975). Neuronal excitability modulation over the sleep cycle: a structural and mathematical model. Science 189, 58-60.
28. 1B knockout mice. Neuropharmacology 28, 850-856.
29. Monti JM, Hawkins M, Jantos H, Labraga P, Fernandez J (1988). Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology 95, 395-400.
30. 1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat. European Journal of Pharmacology 478, 121-130.
31. 1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat. Behavioral Brain Research 151, 159-166.
32. Monti JM, Jantos H, Monti D (2002). Increased REM sleep after intra-dorsal raphe nucleus injection of flesinoxan or 8-OHDPAT: prevention with WAY 100635. European Neuropsychopharmacology 12, 47-55.
33. 1A receptor agonist and antagonists: effect on rapid eye movement sleep in the rat. Sleep Research Online 3, 29-34.
34. Oberndorfer S, Saletu-Zyhlarz G, Saletu B (2000). Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality. Neuropsychobiology 42, 69-81.
35. Pastel RH, Fernstrom JD (1987). Short-term effects of fluoxetine and trifluoromethylphenylpiperazine on electroencephalographic sleep in the rat. Brain Research 436, 92-102.
36. Paxinos G, Watson C (1986). The Rat Brain. Sydney: Academic Press.
37. Perry KW, Fuller RW (1992). Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sciences 50, 1683-1690.
38. Perry KW, Fuller RW (1993). Extracellular 5-hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus L-5-hydroxytryptophan. Journal of Pharmacy and Pharmacology 45, 759-761.
39. Reynolds CF, Kupfer DJ (1987). Sleep research in affective illness: state of the art circa 1987. Sleep 10, 199-215.
40. Rigdon GC, Wang CM (1991). Serotonin uptake blockers inhibit the firing of presumed serotonergic dorsal raphe neurons in vitro. Drug Development Research 22, 135-140.
41. Ross RJ, Ball WA, Gresch PJ, Morrison AR (1990). REM sleep suppression by monoamine reuptake blockade: development of tolerance with repeated drug administration. Biological Psychiatry 28, 231-239.
42. Rutter JJ, Auerbach SB (1993). Acute uptake inhibition increases extracellular serotonin in the rat forebrain. Journal of Pharmacology and Experimental Therapeutics 265, 1319-1324.
43. Sabol KE, Richards JB, Seiden LS (1992). Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Brain Research 585, 421-424.
44. Sanford LD, Ross RJ, Seggos AE, Morrison AR, Ball BA, Mann GL (1994). Central administration of two 5-HT receptor agonists: effect on REM sleep initiation and PGO waves. Pharmacology, Biochemistry and Behavior 49, 93-100.
45. Semba K (1993). Aminergic and cholinergic afferents to REM sleep induction regions of the pontine reticular formation in the rat. Journal of Comparative Neurology 330, 543-556.
46. Sharpley AL, Cowen PJ (1995). Effect of pharmacological treatments on the sleep of depressed patients. Biological Psychiatry 37, 85-98.
47. Slater IH, Jones GT, Moore RA (1978). Inhibition of REM sleep by fluoxetine, a specific inhibitor of serotonin uptake. Neuropharmacology 17, 383-389.
48. Staner L, Luthringer R, Macher J-P (1999). Effects of antidepressant drugs on sleep EEG in patients with major depression. CNS Drugs 11, 49-60.
49. Stevens DR, McCarley RW, Greene RW (1992). Excitatory aminoacid-mediated responses and synaptic potentials in medial pontine reticular formation neurons in the rat in vitro. Journal of Neurosciences 12, 4188-4194.
50. Strecker RE, Thakkar MM, Porkka-Heiskanen T, Dauphin LJ, Bjørkum AA, McCarley RW (1999). Behavioral state-related changes of extracellular serotonin concentration in the pedunculopontine tegmental nucleus: a microdialysis study in freely moving animals. Sleep Research Online 2, 21-27.
51. Thakkar MM, Strecker RE, McCarley RW (1998). Behavioral state control through differential serotonergic inhibition of the mesopontine cholinergic nuclei: a simultaneous unit recording and microdialysis study. Journal of Neurosciences 18, 5490-5497.
52. Tohyama M, Takatsuji K (1998). Atlas of Neuroactive Substances and their Receptors in the Rat. Oxford: Oxford University Press.
53. 1A receptor agonist. Journal of Sleep Research 6 (Suppl. 4), 69.
54. Vertes RP, Kocsis B (1994). Projections of the dorsal raphe nucleus to the brainstem: PHA-L analysis in the rat. Journal of Comparative Neurology 340, 11-26.